Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer

Nuclear Medicine and Biology

Volumn 23, Issue 6, 1996, Pages 681-684

  Palmedo, H ^a   Schomburg, A ^a   Grunwald F ^a   Mallmann, P ^a   Boldt, I ^a   Biersack, H J ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

breast cancer; scintigraphy; technetium 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; BREAST CANCER; CANCER SCINTISCANNING; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY;

EID: 0030221409     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00084-4     Document Type: Conference Paper

References (20)

1. 1. Aktolun C., Bayhan H., Pabuccu Y., Bilgic H., Acar H. and Koylu R. (1994) Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with Tc-99m sestamibi imaging: Comparison with CT scan. Eur. J. Nucl. Med. 21, 973-979.
2. 2. Biersack H. J., Briele B., Hotze A. L., Oehr P., Quian L., Mekkawy M. A. and Shih W. J. (1992) The role of nuclear medicine in oncology. Ann. Nucl. Med. 6(3), 131-136.
3. 3. Briele B., Hotze A., Kropp J., Bockisch A., Overbeck B., Grünwald F., Kaiser W. and Biersack H. J. (1991) A comparison of 201T1 and 99mTc-MIBI in the follow-up of the differentiated thyroid carcinomas. Nuklearmedizin 30(4), 115-124.
4. 4. Caner B., Kitapci M., Unlu M., Erbengi G., Calikoglu T., Gogus T. and Bekdik C. (1992) Tc-99m MIBI uptake in benign and malignant bone lesions: A comparative study with Tc-99m MDP. J. Nucl. Med. 33(3), 319-324.
5. 5. Carter C. L., Allen C. and Henson D. E. (1989) Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 63, 181-187.
6. 6. Habbema J. D. F. van Oortmarssen G. V., van Putten D. J., Lubbe J. T. and van der Maas P. J. (1986) Age-specific reduction in breast cancer mortality by screen: An analysis of the results of Health Insurance Plan of Greater New York study. JNCI 77, 317-320.
7. 7. Kao C. H., Wang S. J. and Liu T. J. (1994) The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur. J. Nucl. Med. 21, 432-436.
8. 8. Kelsey J. L. and Gammon M. D. (1991) The epidemiology of breast cancer. CA 41, 146-165.
9. 9. Khalkhali I., Mena I., Jouanne E., Diggles J., Venegas R., Block J., Alle K. and Klein S. R. (1994) Prone scintimammography in patients with suspicion of breast cancer. J. Am. Coll. Surg. 178, 491-497.
10. 10. Khalkhali I., Cutrone J. A., Mena I., Diggles L., Venegas R., Vargas H., Jackson B., Khalkhali S., Moss J. F. and Klein S. R. (1995) Scintimammography: The complementary role of Tc-99m Sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 196, 421-426.
11. 11. Kopans D. B. (1992) Positive predictive value of mammography. AJR 158, 521-526.
12. 12. Lee V., Sax E. J., McAneny D. B., Pollack S., Blanchard R. A., Beazley R. M., Kavanah M. T. and Ward R. J. (1993) A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J. Nucl. Med. 34, 2095-2100.
13. 13. Mann B. D., Giuliano A. E., Bassett L. W. et al. (1983) Delayed diagnosis of breast cancer as a result of normal mammograms. Arch. Surg. 118, 23-25.
14. 14. O'Tuama L. A., Treves S. T., Larar J. N., Packard A. B., Kwan A. J., Barnes P. D., Scott R. M., Black P. M., Madsen J. R., Goumnerova L. C. et al. (1993). T1-201 versus Tc-99m MIBI SPECT in evaluation of childhood brain tumors: A within-subject comparison. J. Nucl. Med. 34(7), 1045-1051.
15. 15. Palmedo H., Schomburg A., Gruenwald F., Mallmann P., Krebs D. and Biersack H. J. (1996) Scintimammography with Tc-99m MIBI in suspicious breast lesions. J. Nucl. Med. 37, 626-630.
16. 16. Taillefer R., Robidoux A., Lambert R., Turpin S. and Laperrière J. (1995) Tc-99m Sestamibi prone scintunammography to detect primary breast cancer and axillary lymph node involvement. J. Nucl. Med. 36, 1758-1765.
17. 17. Thomas B. A. (1989), The place of clinical examination in breast cancer screening. In: Practical Modalities of an Efficient Screening (Edited by Ziant G.), pp. 11-24. Exerpta Medica, Amsterdam, The Netherlands.
18. 18. Tiling R., Kress K., Pechmann M., Pfluger Th., Knesewitsch P., Tatsch K. and Hahn K. (1995) Integrated diagnosis of breast tumors: Semiquantitative Tc-99m Sestamibi imaging versus dynamic MRI. J. Nucl. Med. 35, 51 (Abstract).
19. 19. Waxman A. D., Ramanna L., Memsic L. D., Foster C. E., Silberman A. W., Gleischmann S. H., Brenner R. J., Brachman M. B., Kuhar C. J. and Yadegar J. (1993) Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J. Nucl. Med. 34, 18-23.
20. 20. Waxman A., Nagaraj N. et al. (1994) Sensitivity and specificity of Tc-99m MIBI in the evaluation of primary carcinoma of the breast: Comparison of palpable and non-palpable lesions with mammography. J. Nucl. Med. 35, 78 (Abstract).